Clinical Trial Update: CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describing CD19 CAR-T cell therapy for adults with relapsed or refractory CD19-positive acute lymphoblastic leukemia, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19 CAR T cells

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Relapsed Refractory Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING